New narcolepsy drug aims to keep patients awake and strong
Symptom relief
Not yet recruiting
This study tests a drug called samelisant in 240 people with narcolepsy (with or without cataplexy). The goal is to see if it reduces excessive daytime sleepiness and sudden muscle weakness episodes over 12 weeks. Participants will take the drug or a placebo and report their slee…
Phase: PHASE3 • Sponsor: Suven Life Sciences Limited • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC